SEC 13F Intelligence

INOVIO PHARMACEUTICALS INC

CUSIP 45773HAB8

Inovio Pharmaceuticals Inc has 4 institutional holders in Filings Flow’s 13F database, together reporting 16.41M shares worth $15M as of Q4 2022. The largest reported holders are D. E. Shaw & Co., Inc., Wolverine Asset Management LLC, and Aqr Arbitrage LLC.

Institutional Holders
4
Q4 2022
Reported Value
$15M
Ticker
unmapped
private placement or foreign
Quarters Tracked
3

Ownership Trend

Institutional holders
Q2 ’21: 4Q2 ’21Q4 ’21: 4Q4 ’21Q4 ’22: 4Q4 ’22filingsflow.com
Total reported value
Q2 ’21: $27MQ2 ’21Q4 ’21: $20MQ4 ’21Q4 ’22: $15MQ4 ’22filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
AQR Arbitrage LLC$6.1B AUM0.16%$4M4.22MQ4 2023
WOLVERINE ASSET MANAGEMENT LLC$10.4B AUM0.05%$5M5.69MQ4 2023
D. E. Shaw & Co., Inc.$166.3B AUM0.01%$6M6.50MQ4 2023

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.